NEU 3.76% $14.35 neuren pharmaceuticals limited

Rightly or wrongly, I think "the market" is looking at the lower...

  1. 1,548 Posts.
    lightbulb Created with Sketch. 164
    Rightly or wrongly, I think "the market" is looking at the lower end of guidance due to the perceived disappointing Q1 sales, so I'm hoping for a surprise to the upside.
    Canadian approval is due mid-October, and if Acadia can replicate the US launch and get to market quickly, we should see a lift in the numbers for Q4 with sales in Nov and Dec.

    My uneducated guesstimate is:
    Q1: 75.9
    Q2: 92.5 (21.9%)
    Q3: 97.1 (5.0%)
    Q4: 126.0 (29.7%)
    Total: 391.5~ USD
    Last edited by mjc159: 08/07/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.35
Change
0.520(3.76%)
Mkt cap ! $1.834B
Open High Low Value Volume
$13.96 $14.35 $13.66 $6.469M 457.9K

Buyers (Bids)

No. Vol. Price($)
3 2023 $14.27
 

Sellers (Offers)

Price($) Vol. No.
$14.38 1777 1
View Market Depth
Last trade - 16.10pm 26/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.